跳至主要内容
临床试验/EUCTR2009-013355-29-GB
EUCTR2009-013355-29-GB进行中(未招募)1 期

A multi-stage clinical study to develop a non-invasive Short Synacthen Test (SST) with nasally administered synacthen and salivary cortisol. The validated non-invasive SST will be used to establish normative data in children and to detect adrenal suppression in asthmatic children. - The development of a non-invasive Short Synacthen Test - NeSST Study

Sheffield Children's NHS Foundation Hospital0 个研究点目标入组 258 人开始时间: 2010年6月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
258

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Stage 1(a+b): Healthy, male volunteers aged 18-64, with no exclusion criteria listed below.
  • Stage 2: Healthy children of either sex, aged between 2 years and 15 years, with no exclusion criteria listed below.
  • Stage 3: Healthy children of both sexes, aged between 6 months and 15 years, without exclusion criteria 1,2,3,5,6,7,8,9,10,11,12 and 14 listed below.
  • Phase 4: Children of both sexes, aged between 6 months and 15 years, prescribed varying doses of regular inhaled corticosteroids and without exclusion criteria 1,5,9,10,11,12 and 14 as listed below.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Past or present history of an endocrinopathy.
  • 2. Past or present history of asthma.
  • 3. Past or present history of allergic rhinitis
  • 4. Past or present history of peptic ulcer disease/GI bleed/significant dyspepsia.
  • 5. Past history of intra-cranial, renal or adrenal pathology.
  • 6. Presently on any prescribed medication.
  • 7. Presently, or within the last 3 months, been prescribed any type of corticosteroid (oral, inhaled, nasal, rectal, intravenous, intramuscular, intra-articular, intra-ocular, topical).
  • 8. Ever been prescribed a prolonged course (more than 1 month) of oral steroids.
  • 9. Previous serious allergic reaction or an episode of anaphylaxis.
  • 10. Previous adverse reaction (including mild hypersensitivity)to ACTH or synacthen.
  • 11. Coryzal symptoms within the last week.
  • 12. Current smoker.
  • 13. Body Mass Index more than 30.
  • 14. Currently pregnant
  • 15. Currently anaemic

研究者

发起方
Sheffield Children's NHS Foundation Hospital

相似试验